↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "(WFRF:(Fazekas F)) srt2:(2015-2019)"

Search: (WFRF:(Fazekas F)) > (2015-2019)

Result 1-10 of 32

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
2.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
3.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
4.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
5.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
6.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)
7.	Schwartz, GG, et al. (author) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 2018 In: The New England journal of medicine. - : MASSACHUSETTS MEDICAL SOC. - 1533-4406 .- 0028-4793. ; 379:22, s. 2097-2107 Journal article (peer-reviewed)
8.	Ridker, PM, et al. (author) Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients 2017 In: The New England journal of medicine. - 1533-4406 .- 0028-4793. ; 376:16, s. 1527-1539 Journal article (peer-reviewed)
9.	Brouwer, F., et al. (author) Energy modelling and the Nexus concept 2018 In: Energy Strategy Reviews. - : Elsevier. - 2211-467X .- 2211-4688. ; 19, s. 1-6 Journal article (peer-reviewed)abstract The Nexus concept is the interconnection between the resources energy, water, food, land and climate. Such interconnections enable to address trade-offs and seek for synergies among them. Several policy areas (e.g. bio-based economy, circular economy) increasingly consider the Nexus concept. Ignoring synergies and trade-offs between energy and natural flows, can generate misleading modelling outcomes. Several modelling tools are available to address energy and the Nexus. Based on six such models, this paper aims to support the design and testing of coherent strategies for sustainable development. Model improvements would be achieved by comparing model outcomes and including a common baseline.
10.	Khalil, M., et al. (author) Neurofilaments as biomarkers in neurological disorders 2018 In: Nature Reviews Neurology. - : Springer Science and Business Media LLC. - 1759-4758 .- 1759-4766. ; 14:10, s. 577-589 Journal article (peer-reviewed)abstract Neuroaxonal damage is the pathological substrate of permanent disability in various neurological disorders. Reliable quantification and longitudinal follow-up of such damage are important for assessing disease activity, monitoring treatment responses, facilitating treatment development and determining prognosis. The neurofilament proteins have promise in this context because their levels rise upon neuroaxonal damage not only in the cerebrospinal fluid (CSF) but also in blood, and they indicate neuroaxonal injury independent of causal pathways. First-generation (immunoblot) and second-generation (enzyme-linked immunosorbent assay) neurofilament assays had limited sensitivity. Third-generation (electrochemiluminescence) and particularly fourth-generation (single-molecule array) assays enable the reliable measurement of neurofilaments throughout the range of concentrations found in blood samples. This technological advancement has paved the way to investigate neurofilaments in a range of neurological disorders. Here, we review what is known about the structure and function of neurofilaments, discuss analytical aspects and knowledge of age-dependent normal ranges of neurofilaments and provide a comprehensive overview of studies on neurofilament light chain as a marker of axonal injury in different neurological disorders, including multiple sclerosis, neurodegenerative dementia, stroke, traumatic brain injury, amyotrophic lateral sclerosis and Parkinson disease. We also consider work needed to explore the value of this axonal damage marker in managing neurological diseases in daily practice.

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 32

Refine your search

Type of publication: journal article (26); conference paper (6)

Type of content: peer-reviewed (27); other academic/artistic (5)

Author/Editor: Fazekas, F. (29); Li, Y. (8); Schmidt, E. (8); Katz, A. (8); Jukema, JW (8); Kim, C. (8); show more...; Malik, A (8); Ferrari, E. (8); Filardi, PP (8); Mach, F (8); Müller, C. (8); Witt, N (8); Shechter, M (8); Probst, V. (8); Laufs, U (8); Baranova, E (8); de Silva, HA (8); Stellbrink, C (8); Dion, D (8); Kim, SH (8); Rasmanis, G (8); Aylward, PE (8); Moriarty, PM (8); Karpov, Y (8); Murin, J (8); Tunon, J (8); Chiang, CE (8); Sritara, P (8); Caccavo, A (8); Mackinnon, IJ (8); Codutti, OR (8); Jure, HO (8); Zaidman, CJ (8); Vico, ML (8); Carnero, GS (8); Colombo, HR (8); Luquez, HA (8); Colquhoun, D (8); Carroll, PA (8); Faes, D (8); Hermans, K (8); De Wolf, L (8); Vervoort, G (8); Roosen, J (8); Cools, F (8); Reis, G (8); Nicolau, JC (8); Silva, RP (8); Maia, LN (8); Rossi, PRF (8); show less...

University: Karolinska Institutet (23); University of Gothenburg (10); Uppsala University (8); Lund University (5); Royal Institute of Technology (1)

Language: English (32)

Research subject (UKÄ/SCB): Medical and Health Sciences (20); Engineering and Technology (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view